 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 1999, 19(21):9618-9634
The Aplysia Mytilus Inhibitory
Peptide-Related Peptides: Identification, Cloning, Processing,
Distribution, and Action
Y.
Fujisawa1,
Y.
Furukawa2,
S.
Ohta3,
T. A.
Ellis4,
N. C.
Dembrow4,
L.
Li5,
P. D.
Floyd5,
J. V.
Sweedler5,
H.
Minakata1,
K.
Nakamaru2,
F.
Morishita2,
O.
Matsushima2,
K. R.
Weiss4, and
F. S.
Vilim4
1 Suntory Institute for Bioorganic Research, Shimamoto,
Mishima, Osaka 618-8503, Japan, 2 Department of Biological
Science, Faculty of Science, Hiroshima University, Kagamiyama,
Higashi-Hiroshima 739-8526, Japan, 3 Instrument Center for
Chemical Analysis, Hiroshima University, Higashi-Hiroshima 739-8526,
Japan, 4 Department of Physiology and Biophysics, Mount
Sinai School of Medicine, New York, New York 10029, and
5 Department of Chemistry and Beckman Institute, University
of Illinois, Urbana, Illinois 61801
 |
ABSTRACT |
Neuropeptides are a ubiquitous class of signaling molecules. In our
attempt to understand the generation of feeding behavior in
Aplysia, we have sought to identify and fully
characterize the neuropeptides operating in this system. Preliminary
evidence indicated that Mytilus inhibitory peptide
(MIP)-like peptides are present and operating in the circuitry that
generates feeding in Aplysia. MIPs were originally
isolated from the bivalve mollusc Mytilus edulis, and
related peptides have been identified in other invertebrate species,
but no precursor has been identified. In this study, we describe the
isolation and characterization of novel Aplysia
MIP-related peptides (AMRPs) and their precursor. Several AMRPs appear
to have some structural and functional features similar to vertebrate
opioid peptides. We use matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry to confirm that all 14 AMRPs
predicted by the precursor are processed in isolated neurons. Northern
analysis, whole-mount in situ hybridization, and
immunohistochemistry are used to map the abundant expression of these
peptides in the CNS and peripheral tissues such as the digestive tract,
vasculature, and the reproductive organs. Physiological studies
demonstrate that the rank order of the inhibitory actions of these
peptides is different for three target muscles. These results
underscore the importance of using a multidisciplinary approach to
identifying and characterizing the actions of neuropeptides in an
effort to gain understanding of their role in systems of interest. The
widespread distribution of the AMRPs indicates that they may be
operating in many different systems of Aplysia.
Key words:
Mytilus inhibitory peptide; neuropeptide; mollusc; Aplysia; cDNA cloning; immunohistochemistry; in situ hybridization; MALDI-TOF MS
 |
INTRODUCTION |
Neuropeptides are a ubiquitous and
diverse class of signaling molecules. Molluscs have been good models
for studying the mechanisms of neurotransmission, which involves a
number of neuropeptides as chemical messengers (Brezina et al., 1996 ;
Vilim et al., 1996a ,b ). The opisthobranch gastropod, Aplysia, is
one of the best-studied molluscs, in which various peptides have been
identified, and the peptidergic neurotransmission has been shown to
play crucial roles in the physiologically important processes such as
feeding, egg laying, and cardioregulation (Scheller et al., 1983 ;
Campanelli and Scheller, 1987 ; Brezina et al., 1995 ). Nevertheless, it
seems likely that additional important peptide transmitters remain to be identified, even in this well-investigated animal. One such set of
unidentified peptides in Aplysia would be a family of
Mytilus inhibitory peptides (MIPs). These neuropeptides were
originally isolated from the bivalve mollusc Mytilus edulis
(Hirata et al., 1988 ; Fujisawa et al., 1991 , 1993 ), and similar
peptides have been identified in other molluscan species (Ikeda et al.,
1992a ,b ; Ohtani et al., 1995 ; Li et al., 1996 ). In general, these
peptides have inhibitory actions on target muscles and hyperpolarize
central neurons (Yongsiri et al., 1989 ; Kiss, 1990 ; Kiss and Osipenko, 1997 ). Although these peptides are likely to play important roles in
the function of many systems in a variety of molluscs, their precursor
protein has yet to be identified in any species.
Neuropepstides are often processed from precursor proteins that code
for other bioactive peptides as well. Often these peptides are
considered to be functionally redundant, but typically have different
potencies on single targets (Brezina et al., 1995 ; Hewes et al., 1998 ;
Perry et al., 1998 ). Furthermore, peptides derived from a single
precursor can affect multiple targets differentially, as in the case of
pro-opiomelanocortin (POMC) or allostatins in insects (Bendena et al.,
1997 ). Thus, it becomes important to characterize the precursor protein
to peptides of interest in the effort to understand their role in
systems of interest.
In preliminary studies, we found that in Aplysia numerous
neurons in the cerebral and buccal ganglia and many axons in the cerebrobuccal connective showed MIP-like immunoreactivity, suggesting that MIP-like peptides may be involved in the central pattern generator
for the feeding system of this animal. In addition, an MIP-related
peptide, GAPRFVamide, was isolated from the extract of the digestive
tract of Aplysia by bioassay using the crop-gizzard preparation (O. Matsushima, unpublished observations). These
results led us to postulate that MIP-related peptides play important
roles in the feeding, and possibly other systems, of
Aplysia.
In the present study, we describe the identification of the
Aplysia MIP-related peptides (AMRPs) and their precursor
using biochemical and molecular techniques. We use matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to demonstrate the processing of the AMRPs from their precursor protein in isolated neurons. Expression of the AMRPs in both CNS and peripheral tissues is also investigated by Northern blot, in
situ hybridization, and immunohistochemistry. The physiological actions of these peptides are investigated on several AMRP-innervated target muscles.
 |
MATERIALS AND METHODS |
Animals
Two species of the opisthobranch mollusc Aplysia were
used, Aplysia kurodai and Aplysia californica.
Animals were kept in tanks filled with artificial seawater (ASW)
continuously aerated at 14-15°C. A. kurodai (50-300 gm)
were caught in Hiroshima Bay, Hamada City (the coast of the Sea of
Japan) and Onahama City (the coast of the Pacific Ocean) in Japan.
These specimens were used for peptide purification within 8 hr of
collection or within 10 d for physiological experiments. Specimens
of A. californica (10-500 gm) were obtained from
Aplysia Research Facility (Miami, FL), Pacific Biomarine
(Venice, CA), and Marinus Inc. (Long Beach, CA). Several larger animals
(up to 1000 gm) were collected off the Monterey Peninsula between
January and July 1998. Animals were used between 3 and 14 d of
receipt. Large animals (200-500 gm) were used for RNA extraction
and MALDI MS, whereas both large and small (10-500 gm) animals were
used for immunocytochemistry and in situ hybridization.
Peptide purification
The cerebral, pedal, and pleural ganglia were isolated from 290 specimens of A. kurodai and immediately frozen in liquid
nitrogen. The ganglia were homogenized by Polytron homogenizer in five
volumes of 80% acetone on ice. The homogenate was centrifuged at
15,000 × g at 4°C for 20 min, and the supernatant
was collected. The obtained supernatant was evaporated to remove
acetone and passed through C18 cartridges (Mega Bond Elut C18; Varian,
Harbor, CA). The cartridges were washed first with 10% methanol
containing 0.1% trifluoroacetic acid (TFA) and then eluted with 60%
methanol-0.1% TFA. The eluate was concentrated to a small volume and
loaded onto a reversed-phase HPLC column (Capcell Pak C18; Shiseido, Tokyo, Japan) and eluted with a linear gradient of acetonitrile (0-60% in 60 min) containing 0.1% TFA at a flow rate of 1.0 ml/min. Fractions of 1 ml each were collected, and an aliquot of each fraction
was applied to a competitive ELISA using the anti-MIP antibody
raised against GSPMFVamide (WM1) as described previously (Fujisawa,
1996 ). Immunopositive fractions were separately applied onto a
cation-exchange column (TSKgel SP-5PW; Tosoh, Tokyo, Japan) equilibrated with 10 mM sodium phosphate buffer,
pH 6.7, and eluted with a linear gradient of NaCl (0-0.6
M for 60 min). The MIP-like immunoreactivity of
each fraction was measured by the ELISA, and positive fractions were
purified by alternating reversed-phase HPLC and ELISA to produce single
UV-absorbance peaks.
Structural analysis
Amino acid sequences of the purified peptides were determined by
automatic peptide sequencer (PSQ-1; Shimadzu, Kyoto, Japan). Fast atom
bombardment mass spectrometry (FAB-MS) was performed for all the
peptides (SX-102A; JEOL, Tokyo, Japan) to determine C-terminal
amidation, because a peptide with free C terminus and that of an
amidated form have different molecular masses. To confirm the
structures, peptides with the predicted sequences were chemically synthesized on the automated peptide synthesizer (PSSM-8; Shimadzu), and co-chromatographed with the purified peptides on a
reversed-phase HPLC column.
Cloning
Standard molecular techniques (Sambrook et al., 1989 ) were used
except where noted. Aplysia californica ganglion cDNA
library was a gift of Dr. Gregg Nagle. The library, a directional
Uni-Zap Lambda phage library (Stratagene, La Jolla, CA), was used both as a template for PCR and for conventional hybridization screening. Seminested degenerate rapid amplification of cDNA ends was
performed using two vector primers and antisense degenerate primers
designed to GAPRFVG (CCI ACR AAI CKI GGI GCI CC). PCR was performed in two stages on a Robocycler Gradient 40 thermal cycler (Stratagene) using taq DNA polymerase and dNTPs from Perkin-Elmer (Norwalk, CT).
Both stages were cycled 25 times for 30 sec at 95°C, 1 min at the
annealing temperature, and 2 min at 72°C. Three separate annealing
temperatures (50, 54, and 58°C) were run in parallel, and a set
without the degenerate primer was used as a control. The reactions were
hot started and not allowed to cool to <72°C between the stages. In
the first stage, 10 µl reactions containing 0.1 µM vector primer (ACC ATG ATT ACG CCA AG), 0.1 µM degenerate primer, 100 µM dNTPs, and 0.1 µl of library were
hot-started with 0.1 U of taq in 0.5 µl of reaction buffer. In the
second stage, 50 µl of prewarmed (72°C) reaction mix containing 1 µM nested vector primer (AAT TAA CCC TCA CTA
AAG), 1 µM degenerate primer, and 100 µM dNTPs was added to each tube then
hot-started again with 1 U of taq.
The results of the PCR were assessed using agarose gel electrophoresis,
and the highest temperature reactions showing significantly more
product than the matched degenerate primerless control were polyethylene glycol-precipitated and TA-cloned (Invitrogen, Carlsbad, CA). Insert-bearing clones were identified using colony PCR, then cycle-sequenced with dye termination (Perkin-Elmer/Applied Biosystems). Inserts from promising degenerate clones were isolated and labeled using 32P-dCTP and random primers (New
England Biolabs, Beverly, MA). These probes were then used to screen a
library to identify full-length clones. At least two independent clones
were sequenced for all regions using a combination of restriction,
deletion, and primer walking. Sequence alignments were generated using
Geneworks version 2.1, and consensus contigs were assembled manually.
Mass spectrometry
Cellular sample preparation. Ganglia with intact
connectives and commissures were removed after an injection of 390 mM MgCl2 equal to 50% of each
animal's body weight. In some cases, a moderate protease treatment
(e.g., 1% protease Type IX for 30-60 min at 34°C) was used to
soften the connective tissues before cell dissection. Extracellular
salts were removed by a previously described approach (Garden et al.,
1996 ). Briefly, the pleural ganglia were isolated and pinned down, and
the physiological saline was replaced with an aqueous MALDI matrix
solution, 10 mg/ml of 2,5-dihydroxybenzoic acid (DHB; ICN
Pharmaceuticals, Costa Mesa, CA). Specific cells were identified and
isolated based on the immunostaining results. Tungsten needles were
used to isolate individual or group of cells onto a MALDI sample plate
containing 0.5 µl of matrix solution. After drying at ambient
temperature, samples were either frozen for future analysis or analyzed immediately.
Microbore-liquid chromatography of cellular homogenates.
Fifty three abdominal ganglia were collected on dry ice and
subsequently stored at 80°C. Peptide extracts were made in 500 µl
of acidified acetone (40:6:1 acetone:water:HCl) according to previous
methods (Floyd et al., 1999 ). Samples were homogenized in a
microhomogenizer (Jencons Scientific Ltd.), sonicated for 5 min
(model 2200; Branson, Danbury, CT), and centrifuged for 10 min at
13,000 rpm in a microcentrifuge (Baxter, McGaw Park, IL). The
supernatant was removed, freeze-dried (Labconco; Fisher Scientific,
Itasca, IL), and resuspended in 500 µl of 2% acetonitrile in 0.1%
aqueous TFA. Two hundred and fifty microliters of the extract
was injected in a reversed-phase microbore liquid chromatography (LC)
instrument (Magic 2002; Michrom BioResources, Auburn, CA)
consisting of a Reliasil C-18 column (0.5 × 150 mm) with 300 Å packing. The flow rate was 150 µl/min at ambient temperature. The
column was equilibrated with solvent A (98% H2O,
0.1% TFA, and 1.9% acetonitrile), and a gradient was developed from
0-80% of solvent B (90% acetonitrile, 9.9%
H2O, and 0.1% TFA) for 30 min and then from
80-98% of solvent B for 10 min. Samples were collected by a fraction
collector (FC 203B; Gilson, Middletown, WI), and each fraction was
screened by MALDI-TOF MS; 0.25 µl of each HPLC fraction was deposited
onto a MALDI sample plate followed by the same volume of
-cyano-4-hydroxycinnamic acid (Sigma, St. Louis, MO) matrix solution.
MALDI-TOF MS. Mass spectra were obtained using a
Voyager DE-STR mass spectrometer equipped with delayed ion extraction
(PE Biosystems, Framingham, MA). A pulsed nitrogen laser (337 nm) was
used as the desorption/ionization source, and positive-ion mass spectra
were acquired using both linear and reflectron mode. Each
representative mass spectrum shown is average of 128-256 laser pulses.
Mass calibration was performed internally using identified peptides
FMRFamide (m/z 599.33) and myomodulin C (MM-C; m/z 861.45) as calibrants. Laser power and delay time were
optimized for each type of samples (i.e., single cells and LC
fractions). Mass spectral peaks were assigned based on combination of
observed masses and the knowledge of prohormone sequences.
Post-source decay. Equal volumes of an HPLC fraction and
matrix solution were either premixed in the vial or mixed on the MALDI
sample plate. The matrix used was 10 mg/ml -cyano-4-hydroxy-cinnamic acid (dissolved in 6:3:1 acetonitrile:water:3% TFA) (Aldrich, Milwaukee, WI). Post-source decay (PSD) analysis was performed with a Voyager DE-STR mass spectrometer in reflectron mode. The total
acceleration voltage was 20 kV with a 75 nsec delay time. Spectra were
obtained by accumulating data from 100-256 laser shots. To obtain
complete PSD spectra, a series of reflectron TOF spectral segments were
acquired, each optimized to focus fragment ions within different
m/z ranges. Segments of each were stitched together to
generate a composite PSD spectrum.
Northern analysis
The buccal, cerebral, pleural, pedal, and abdominal ganglia were
separately dissected and pooled from five animals (A. californica) anesthetized with 50% volume of isotonic
MgCl2. RNA was isolated by the acid-phenol method
of Chomcyznski and Sacchi (1987) . RNA was fractionated on a
3[N-morpholino]propanesulfonic acid (MOPS)/formaldehyde 1.5% agarose gel and downward transferred (turboblotter; Schleicher & Schuell, Keene, NH) overnight with 20× standard saline phosphate EDTA
(SSPE) onto positively charged nylon (Biodyne B; Life Technologies, Gaithersburg, MD). The RNA was UV-crosslinked (Stratalinker;
Stratagene), then washed with diethyl pyrocarbonate-treated water and
stained with methylene blue (0.2% methylene blue/0.3
M sodium acetate, pH 5.5). The blot was scanned
to document the loading and transfer of the RNA. The positions of the
lanes and the bands in the RNA marker lane (Novagen, Madison, WI) were
noted on the membrane with a number 2 pencil. After complete destaining
in 1% SDS-0.1× SSPE, the blots were prehybridized (50% formamide,
7% SDS, 250 mM sodium phosphate, pH 7.2, 10 mM EDTA, and 10% dextran sulfate) for 1 hr at
50°C in a rotary oven (Hybaid, Franklin, MA). The blot was then
hybridized with random primer-labeled (New England Biolabs) probe
overnight at 50°C. Washes were performed 2 × 15 min at room
temperature (RT) with 2× SSPE-0.1% SDS, then at 50°C for 1 hr with
0.1× SSPE-0.1% SDS. Blots were wrapped in saran and exposed to film.
Autoradiograms were aligned with the blots, and the positions of the
markers were noted. They were then scanned and assembled into final
figures using Photoshop 3.0.
New antibodies
The antigen was prepared by coupling GSPRFFamide (AnaSpec Inc.,
San Jose, CA) to BSA (Sigma, catalog #A0281) using either 1-ethyl-3-(dimethylaminopropyl)carbodiimide (EDC) (Sigma, catalog #E7750) or paraformaldehyde-glutaraldehyde (PfG) (EM Sciences, Fort
Washington PA). The coupling was performed in a 0.5 ml volume of 50 mM NaH2PO4, pH
7.2, containing 5 mg of BSA, 1 mg of peptide, and either 10 mg of EDC
or 1% paraformaldehyde and 0.1% glutaraldehyde. The mixture was
allowed to react overnight at 4°C, and then the coupled antigen was
purified from the reaction using a Microcon-30 (spinning at 13,800 × g for 30 min at 4°C to concentrate). After washing the
retentate four times with 0.4 ml of 50 mM
NaH2PO4, pH 7.2, it was
resuspended in 0.5 ml of the same buffer and transferred to a new tube.
Two male Sprague Dawley rats (Teconic; 250-300 gm) were immunized by
intraperitoneal injection with 12.5 µl (~125 µg) of antigen in an
emulsion of 0.5 ml of PBS and 0.5 ml of Freund's complete adjuvant. At 21 and 42 d after initial injection, the rats were boosted by intraperitoneal injection with 6.25 µl (~62.5 µg) of antigen in an emulsion of 0.5 ml of PBS and 0.5 ml of Freund's incomplete adjuvant. The animals were killed by decapitation at 49 d after initial injection; the blood was harvested and
processed for serum. Sera were aliquoted, frozen, and lyophilized, or
stored at 4°C with EDTA (25 mM final) and thimerosal
(0.1% final) added as stabilizers.
Of the two antibodies we made, EDC-coupled antigen gave more specific
immunostaining than PfG-coupled antigen, because PfG stained almost
twice as many neurons than EDC. Furthermore, EDC-immunopositive neurons
were the most consistent with the in situ
hybridization-positive neurons and the Northern analysis of the
distribution of the AMRP precursor mRNA in the different ganglia.
Therefore, all subsequent immunostaining analysis we report here was
done with the antibody made to EDC-coupled GSPRFFamide-BSA antigen.
Immunostaining with this antibody was abolished by preincubation with
10 4 M GSPRFFamide
(data not shown).
In situ hybridization
The whole-mount in situ hybridization protocol used in this
study is a modification of a method established for tunicate embryos (Makabe et al., 1992 ). Animals (A. californica) were
anesthetized with 50% volume injection of isotonic
MgCl2, and the desired ganglia and tissues were
dissected and removed. The tissues were pinned out in the desired
orientation in 50% isotonic MgCl2-50% ASW. All
subsequent reagents and solutions used in the in situ
hybridization were made with diethyl pyrocarbonate-treated MilliQ
water, and care was taken to avoid contamination with RNases. Tissues
were fixed in 4% paraformaldehyde, 0.5 M NaCl,
and 0.1 M MOPS, pH 7.5, for 3 hr at RT or
overnight at 4°C, then washed for 3 × 10 min at RT in PBT
(0.8% NaCl, 0.02% KCl, 0.3%
Na2HPO4-12
H2O, 0.02% KH2PO4, and 0.1% Tween 20, pH 7.4). The tissue was digested with 50 µg/ml of proteinase K in PBT
for 30 min at 37°C, then washed again with PBT for 3 × 10 min
at RT. The tissue was post-fixed with 4% paraformaldehyde in PBT for 1 hr at RT, then washed once more for 3 × 10 min at RT with PBT.
The tissue was prehybridized for 1 hr at 42°C in hyb-buffer (5× SSC,
1% blocking reagent, 50 µg/ml salmon sperm DNA, 0.1% sarkosyl, and
0.02% SDS) and then hybridized overnight at 42°C in hyb-buffer
containing 1 µg/ml of the labeled oligo. Oligos were labeled by
tailing with digoxigenin (DIG)-dUTP/dATP according to the
manufacturer's instructions (Boehringer Mannheim, Indianapolis, IN).
Unbound probe was washed out with 2× SSC and 0.01% SDS for 3 × 1 hr at 42°C then with PBT for 2 × 10 min at RT. The tissue was
blocked with 1% blocking reagent (Boehringer, catalog #1096176) in
0.15 M NaCl and 0.1 M
maleic acid, pH 7.5, for 3 hr at RT and then incubated in 1:200
dilution of anti-DIG antibody labeled with alkaline phosphatase
(Boehringer, catalog #1093274) in blocking solution for 24 hr at 4°C.
Unbound antibody was washed out with PBT for 5 × 1 hr at RT, then
washed with detection buffer (0.1 M Tris, 0.1 M NaCl, 5 mM
MgCl2, and 10 mM
levamisole) for 2 × 30 min at RT. The signal was developed for 30 min at RT with detection buffer containing 350 µg/ml nitroblue tetrazolium, 175 µg/ml 5-bromo-4-chloro-3-indolyl phosphate, and 0.1% Tween 20, and the reaction was then stopped by washing the tissue
with PBT containing 1 mM EDTA (PBTE). The tissues
were post-fixed with 4% paraformaldehyde in PBT for overnight at
4°C. After washing with PBT, they were stored protected from light in
50% glycerol and PBTE at 4°C. Selected preparations were
photographed on a Nikon microscope, and the negatives were scanned and
compiled into figures with Photoshop 3.0.
Immunocytochemistry
Immunocytochemistry was performed on A. californica
as previously described (Vilim et al., 1996a ). Tissues were fixed in
freshly prepared fixative (4% paraformaldehyde, 0.2% picric acid,
25% sucrose, and 0.1 M
NaH2PO4, pH 7.6) for either
3 hr at RT or overnight at 4°C. After washes with PBS to remove the
fixative, the ganglia from large animals were desheathed to expose the
neurons. Ganglia from small animals (10-15 gm) were processed without
desheathing. All subsequent incubations were done at RT with rocking.
Tissue was permeabilized and blocked by overnight incubation in
blocking buffer (BB; 10% normal donkey serum, 2% Triton X-100, 1%
BSA, 154 mM NaCl, 10 mM
Na2HPO4, 50 mM EDTA, and 0.01% thimerosal, pH 7.4). Primary
antibody was diluted 1:250 in BB and incubated with the tissue for 4-7
d. The tissue was then washed twice a day for 2-3 d with washing
buffer (WB; 2% Triton X-100, 1% BSA, 154 mM
NaCl, 10 mM
Na2HPO4, 50 mM EDTA, and 0.01% thimerosal, pH 7.4). After
the washes, the tissue was incubated with 1:500 dilution of secondary
antibody (lissamine-rhodamine donkey anti-rat; Jackson ImmunoResearch,
West Grove, PA) for 2-3 d. The tissue was then washed twice with WB
for 1 d and 4 times with storage buffer (SB; 1% BSA, 154 mM NaCl, 10 mM
Na2HPO4, 50 mM EDTA, and 0.01% thimerosal, pH 7.4) for
1 d. The tissues were then stored at 4°C or viewed and
photographed on a Nikon microscope equipped with epifluorescence
(Morrell Instrument Co., Melville, NY). Negatives were scanned and
compiled into figures using Photoshop 3.0.
Recording of muscle contractions
Animals (A. kurodai) were anesthetized by injecting
isotonic MgCl2 solution before dissection. The
esophagus, the dorsal longitudinal muscle of the inner body wall, and
the penis retractor muscle (1-1.5 cm in length) were excised from the
animal, and then both ends of them were tied with cotton thread. One
end was fixed to a chamber filled with ASW (2 ml), and the other was
fixed to a force transducer. In the case of the esophagus, the chamber
was continuously aerated, and 20 µl of peptide solutions at 100×
concentration was injected into the chamber. Tension changes of the
spontaneous contractions of the esophagus were recorded on a thermal
pen recorder. In the case of the body wall muscle and the penis
retractor muscle, the chamber was not aerated, and electrical
stimulation was applied to evoke tetanic contractions at 10 min
intervals. Peptide solutions dissolved in ASW at final concentration
were applied to the preparations by exchanging the whole chamber content.
 |
RESULTS |
Isolation of five AMRPs from the CNS of Aplysia
By means of the competitive ELISA combined with HPLC purification,
five peptides were isolated from the acetone extract of the cerebral,
pedal, and pleural ganglia of Aplysia kurodai. Figure 1 shows an example of purification steps
for one of the five peptides, GAPRFVamide. Results of amino acid
sequence analysis and FAB-MS measurement indicated that the five
peptides are all hexapeptides with the amidated C terminus (Table
1). Co-chromatography experiments using
the synthetic and the purified peptides confirmed the predicted structures (data not shown). Therefore, the structures of the isolated
peptides were determined as follows: GAPRFVamide, GAPRFIamide, GPPRFIamide, GSPHFIamide, and GSPRFFamide. It is notable that GAPRFVamide was identified both in the gut and the CNS extracts. The
five peptides thus isolated from the CNS of Aplysia were
apparently homologous to the known MIP-related peptides; they possessed
the conserved structure-PXFV/Iamide, characteristic to the MIP family, except for GSPRFFamide. However, the substitution of
Phe6 is a conservative change, which in
turn means that GSPRFFamide can be regarded as an MIP-related peptide.
Therefore, we designated the five peptides AMRPs.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 1.
Purification of GAPRFVamide from the CNS of
Aplysia using immunoassay. A, First
separation step of reversed-phase HPLC. The column (Capcell Pak C18;
10 × 250 mm) was developed by 0-60% acetonitrile and 0.1% TFA.
A shaded bar indicates the immunoreactive fraction from
which GAPRFVamide was purified. B, Second step of
cation-exchange HPLC. The column (TSKgel SP-5PW; 7.5 × 75 mm) was
eluted with a gradient of 0-0.6 M NaCl and 10 mM sodium phosphate buffer, pH 6.7) A shaded
bar indicates the immunoreactive fraction that was subjected to
the next HPLC step. C, Final step of reversed-phase
HPLC. The column (TSKgel ODS-80TM; 4.6 × 150 mm) was eluted by
15-25% acetonitrile and 0.1% TFA. Arrow indicates a
peak of the purified peptide.
|
|
Cloning of the Aplysia AMRP precursor mRNA
Because GAPRFVamide was isolated both on the basis of bioactivity
and immunoreactivity, we decided to focus on this peptide to clone the
precursor. The seminested degenerate PCR yielded several clones which,
upstream of the degenerate primer to GAPRFVamide, coded for other
peptides in the MIP family. This unequivocally demonstrated to us that
we had the correct mRNA species. Sequencing of the cDNA clones isolated
by library screening generated a 3262 bp consensus sequence (GenBank
accession number AF160191). Northern analysis indicated that the mRNA
is ~3.3 kb (see Fig. 5), which suggests that the sequence is very
near to full length and is expressed in the ganglia of
Aplysia.
The predicted mRNA contained a 2205 bp open reading frame that coded
for a 735 amino acid precursor shown in Figure
2. The precursor had a predicted
hydrophobic signal peptide and a predicted cleavage site between
Ser20 and
Phe21 (Nielsen et al., 1997 ), indicating
that the protein is targeted to the secretory pathway. There was an
unusual glutamine-rich region on the precursor between the signal
peptide and the first AMRP. The precursor coded for a total of 26 copies of 14 different predicted amidated peptides as indicated by
C-terminal glycines, monobasic, dibasic, and tribasic residues (Eipper
et al., 1992 ; Sediah and Chreiten, 1997 ). The distribution of these
peptides on the precursor is shown in Figure
3. At least 21 connecting or linker
peptides were also predicted by the precursor, most of which are acidic
in nature. In many precursors, these acidic connecting peptides are
degraded and have been postulated to compensate for the basic nature of
the processing sites. However, some connecting peptides have been
demonstrated to survive processing and targeting, and to have
bioactivity (Fan et al., 1997 ). The MALDI-TOF MS data described below
indicate that at least some of these connecting peptides are present in
the soma of AMRP-containing neurons (see below).

View larger version (40K):
[in this window]
[in a new window]
|
Figure 2.
Predicted amino acid sequence of the AMRP
precursor. Amino acids are numbered at right, and
predicted amidated peptides are underlined. Monobasic,
dibasic, and tribasic cleavage sites are shown in bold,
and an asterisk denotes predicted signal sequence
cleavage site (SS-FS).
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Figure 3.
Organization of the AMRP precursor.
A, Scale drawing of a partial restriction map of the
AMRP precursor mRNA. Open reading frame is shown in a darker
shade of gray. B-D are scale
drawings comparing different aspects of the AMRP precursor protein.
B, Kyte-Doolittle hydropathy plot of the AMRP precursor
protein. The initial hydrophobic upward deflection denotes the signal
peptide. C, The distribution of the predicted amidated
peptides shown as gray bars. Connecting peptides are
shown as the intervening white regions.
Half-height line denotes position of predicted signal
peptide cleavage. D, Distribution in the AMRP precursor
of acidic (D1) and basic (D2) residues
shown as vertical lines. For acidic residues
(D1), full height lines represent
glutamate residues, and two-thirds-height lines
represent aspartate residues. For basic residues
(D2), full height lines represent
arginine residues, two-thirds-height
lines represent lysine residues, and
one-third-height lines represent histidine residues.
Note acidic nature of the connecting peptides and basic residues
flanking the predicted amidated peptides. For comparison, scale is
identical in parts B-D with amino acids numbered at
bottom.
|
|
It is interesting to note that 17 of 26 copies of AMRPs predicted by
the precursor are FFamides. This motif is similar to the recently
discovered putative µ opiate receptor ligand neuropeptide endomorphin
2 (YPFFamide; Zadina et al., 1997 ). Furthermore, there are two AMRPs,
SDPFFMamide and GAPRFLamide, of which the two C-terminal amino acids
are identical to Met (YGGFM) and Leu (YGGFL) enkephalin, respectively
(Harrison et al., 1998 ).
Processing of the AMRP precursor
Five of the amidated peptides predicted by the AMRP precursor have
been biochemically isolated and sequenced, thus confirming that they
are in fact made. The other nine peptides predicted by the precursor
needed confirmation that they are in fact processed out from the
precursor as predicted. This is especially true because some of the
C-terminal single arginine processing sites do not fall cleanly into
the known consensus sites (Sediah and Chreiten, 1997 ) K/R-Xn-K/R-cut
where n = 0, 2, 4, 6, and 8 (i.e., GAAPKFFamide, n = 3; AAPRFFamide, n = 9, 10, 11). For
this purpose, we used MALDI-TOF MS, which has been shown to be an
excellent method for identification of peptide products of gene
expression and post-translational processing (Jimenez et al., 1994 ;
Garden et al., 1998 ; Li et al., 1998 ; Worster et al., 1998 ).
Figure 4 shows a representative mass spectrum obtained from
a small group of cells (~5-8 cells) in the right pleural ganglion close to the cerebropleural connective, which had been indicated to
contain AMRPs by in situ hybridization and immunostaining
(see below). FMRFamide and MM-C detected in the spectrum (Fig.
4) were used as internal calibrants to provide improved
mass accuracy for AMRPs. As clearly shown in Figure 4, molecular ion
peaks corresponding to each of the 14 putative amidated peptides were
observed, confirming the synthesis of all the 14 predicted peptides on
the AMRP precursor. Furthermore, two peptides (QAPRFIamide and
QAPRFFamide) contain an N-terminal Gln, and hence can form
pyroglutamate (pGlu) forms. Both native and pGlu forms of these
peptides were detected. The peptides GAPRFIamide and GAPRFLamide have
the same molecular mass peak (as Ile and Leu are isomers), which was
observed. In addition, the amidated peptides with n = 3 and n = 9, 10, 11 cleavage sites (see above) were found
to be processed from the precursor. Table 2 shows the mass accuracy of measurements
in both cellular samples and HPLC fractions. The average error of
measurements for both types of samples are 20 and 14 ppm, respectively,
excellent compared to previous cell work (Jimenez et al., 1994 ; Garden
et al., 1998 ; Li et al., 1998 ).

View larger version (42K):
[in this window]
[in a new window]
|
Figure 4.
MALDI-TOF MS in single neurons of the pleural
ganglion. A mass spectrum in the 550-1000 Da range from isolated
pleural neurons. Assigned peaks are labeled with corresponding
peptides. Peptides derived from three precursors, FMRFamide,
myomodulin, and AMRP are detected. The inset box shows
the numbering scheme used for the AMRP peptides. P
indicates a pGlu-modified form of the two AMRPs containing N-terminal
Gln. Connecting peptide S[279-287]L is SDDNVALDL, and Q[259-267]A
is QDDDIMIAA.
|
|
In addition to the amidated AMRP peptides, a number of presumed linker
peptides are predicted from the prohormone, with most occurring at
higher molecular masses. In several cases in gastropod molluscs, such
peptides are rapidly degraded, and some of these intermediates can be
detected with MALDI MS (de With et al., 1997 ; Garden et al., 1998 ).
Several of these linker peptides predicted by the prohormone were also
detected in the spectra (data not shown). Table
3 lists several of the putative linker
peptides cleaved between dibasic sites that we detected in these cell
samples. It remains to be determined whether these peptides were in the process of being degraded or if they are retained and possess bioactivity.
To confirm our assignments, primary structural information of a
peptide detected with MALDI-MS can be obtained using PSD analysis (Kaufmann et al., 1993 ; Spengler, 1997 ). Because PSD analysis requires
both more concentrated samples and a greater amount of samples than
those generally provided by a cell or cells, multiple ganglia were
pooled, homogenized, and separated using HPLC. PSD analysis was
performed on several LC fractions to obtain full or partial sequence
information from the most intense putative AMRP peptide peaks. We were
able to use PSD (data not shown) to confirm that GAPRFVa, GPPRFIa, and
GSPRFFa are authentic AMRPs, as predicted by the gene, and partially
confirm (i.e., a partial sequence obtained) for QAPRFIa and QAPRFFa.
Taken together, the simultaneous detection of all predicted amidated
peptides and several putative linker peptides encoded by the AMRP gene
in a single group of cells and sequencing five of them using PSD both confirmed the gene sequence and verified its expression in the Aplysia CNS. Because not all the neurons expressing the
AMRPs in the CNS have been analyzed, the possibility that not all of these neurons express all 14 AMRPs cannot be ruled out.
Distribution of AMRP-containing neurons and their processes
in Aplysia
Cross-correlation of the results from Northern analysis, in
situ hybridization, and immunocytochemistry was used to map
AMRP-containing neurons and their processes. For selected identifiable
neurons, MALDI-TOF MS was also used to confirm the presence of AMRPs.
Each of these methods has its own strengths and limitations, which when
combined, can increase the validity of mapping.
Northern analysis was performed to identify the length and overall
distribution of the mRNA that codes for the AMRP precursor. The
Northern blot was hybridized with a random primer
32P-labeled a probe using a template
corresponding to the peptide-coding region (~1600-2300) of the
sequence. Figure 5 shows that the mRNA coding for the AMRPs is a single band ~3.3 kb in length that
corresponds well with the size of longest clones isolated from the
library. The mRNA has highest levels in the pleural ganglion, with
somewhat lesser amount in the abdominal ganglion. The cerebral, buccal, and pedal have relatively low amounts of the AMRP precursor mRNA with
approximately cerebral > buccal > pedal. The methylene blue staining of the ribosomal RNA shows equal loading in all the lanes. The
relative amounts of mRNA in the different ganglia serve as a benchmark
to assess the validity of the in situ hybridization and
immunohistochemistry results.

View larger version (66K):
[in this window]
[in a new window]
|
Figure 5.
Northern analysis of AMRP mRNA. A,
Methylene blue-stained Northern blot of total RNA isolated from the
five different ganglia of Aplysia californica showing
equal loading in all lanes. Aplysia ribosomal RNA runs
as a single 18 S band. B, Hybridization of the same blot
with AMRP coding sequence probe. Kb, Kilobase;
M, RNA size marker; B, buccal ganglion;
C, cerebral ganglion; L, pleural
ganglion; E, pedal ganglion; A, abdominal
ganglion.
|
|
In situ hybridization was performed to get a more precise
distribution of the mRNA that codes for the AMRP precursor. Several controls were used to assess the validity of the in situ
hybridization results. First, hybridization with a control labeled
oligo resulted in the absence of staining. Second, using two different
antisense oligos directed against different parts of the AMRP mRNA
sequence gave identical staining patterns (GAP 3a, TGC TGA CTC ACC AGA CGA CTT; GAP-ISH, CCA AAA AAT CTG GGY GAA CCT C; data not shown). One
of these oligos (GAP-ISH) was designed against repetitive sequences in
the AMRP mRNA, thus hybridizing multiply, and consequently giving
stronger signals. The GAP-ISH oligo was subsequently used in all the
analyses. Third, the distribution of in situ
hybridization-positive neurons can be correlated to the distribution of
immunopositive neurons (see below). The distribution of the mRNA as
shown by in situ hybridization is consistent with the
results of the Northern analysis. The highest density of in
situ hybridization-positive neurons was observed in the pleural
and abdominal ganglia, with lower densities observed in the cerebral,
buccal, and pedal ganglia. We also observed in situ
hybridization-positive neurons in the crop, filtering chamber, and in
the stomatogastric ring.
Immunocytochemistry was used to map the AMRP-synthesizing neurons and
their processes. Several controls were used to assess the validity of
the AMRP immunostaining. First, the abolition of immunostaining by
preadsorption of the antibody with peptide was confirmed. Second, the
correlation of the amount of immunostaining in the different ganglia
with the amount of mRNA as detected by Northern analysis was verified.
Third, the correlation of the immunopositive neurons with in
situ hybridization-positive neurons was confirmed. Initial
experiments using the antibody to GSPMFVamide (the original MIP)
immunostained more neurons than predicted from Northern and
in situ results (e.g., many immunopositive neurons in the
pedal ganglion), suggesting that additional cDNAs code for
immunologically similar peptides. This result also necessitated that a
more specific antibody be made, and GSPRFFamide was chosen as the
antigen because it exists in 11 copies on the precursor. Of the two
antibodies made, the EDC-coupled antigen gave results that correlated
the best with Northern and in situ results and thus was used
for all subsequent experiments. In addition, preadsorption of this
antibody with 10 4
M GSPRFFamide completely abolished immunostaining
(data not shown).
The ganglia from both large (100-300 gm) and small (10-15 gm) animals
were used for in situ hybridization and immunostaining with
the AMRP antibody. The ganglia from small (10-15 gm) animals are shown
in Figures 7-9, except where noted. There was some variability in the
number and size of neurons staining in different animals, even in the
same weight range. What we present are the typical results from both
large and small animals. A diagram summarizing the distribution of
AMRP-positive neurons in each ganglion represents the correlated
results of in situ hybridization and immunocytochemistry. Locations of the nerves in the drawings are intended as landmarks, the
relative positions of the neurons and nerves vary somewhat from animal
to animal and depending on how the ganglia are pinned. To avoid
redundancy, neurons that were observed to be both immunopositive and
in situ hybridization-positive are referred to as
AMRP-positive below. Because in situ hybridization cannot be
used to define processes of neurons, cross-correlation is not possible.
It is likely that immunostaining of processes reflects the presence of
bona fide AMRPs because of the excellent cross-correlation of in
situ hybridization and immunostaining of neuronal cell bodies.
Buccal ganglion (Fig. 6)
Two intensely AMRP-positive neurons were observed in each
hemiganglion. The neurons were typically present on the dorsocaudal aspect in the region of the sensory neurons. Dense immunostaining was
observed in the neuropil of the buccal ganglion, particularly in the
region of the B1 B2 cluster
(Fig. 6B2, inset). These immunostained processes
seemed to envelop the proximal axons of the neurons in this cluster. In
the buccal nerves, a large number of immunostained axons were observed
in the esophageal nerve. Several immunostained axons were also observed
in the cerebrobuccal connective (Fig. 6A2, inset).
Typically, only a few immunostained axons were observed in nerve 1, and
none were observed in nerve 2, nerve 3, and radular nerve.

View larger version (46K):
[in this window]
[in a new window]
|
Figure 6.
AMRP neurons in the buccal ganglion.
A1, In situ hybridization of rostral
surface. A2, Immunocytochemistry of rostral surface.
Inset is same region as arrow from an
adult animal showing immunoreactive axons in the CBC.
A3, Drawing of the AMRP neurons on the rostral buccal
ganglion. B1, In situ hybridization of
caudal surface. B2, Immunocytochemistry of caudal
surface. Inset is the same region as
arrow in an adult animal showing dense innervation of
the B1-B2 cluster. B3, Drawing of the AMRP neurons on
the caudobuccal ganglion. CBC, Cerebrobuccal connective;
N1, nerve 1 (B4); N2, nerve 2 (B5);
N3, nerve 3 (B6); SN, salivary nerve
(B3); EN, esophageal nerve (B2); RN,
radula nerve (B1). Scale bar: A1, 500 µm (same in all
panels, including insets).
|
|
Cerebral ganglion (Fig. 7)
On the dorsal surface (Fig. 7A1-3), there were two
clusters (20-30 neurons each) of 20-50 µm AMRP-positive neurons in
each hemiganglion. One of these was in the F cluster [nomenclature after Jahan-Parwar and Fredman (1976) ], the other was in the A cluster
near the base of the cerebropedal connective. The A cluster AMRP-positive neurons ventralized in adult animals, although they were
still located on top of the cerebropleural connective. A third cluster
of very small (10-20 µm) AMRP-positive neurons was located in the M
cluster between the upper labial and anterior tentacular nerves. In
addition, there were two larger (50-100 µm) intensely staining
AMRP-positive neurons in each dorsal hemiganglion, one in the D
cluster, the other between the D and E clusters. On the ventral surface
(Fig. 7B1-3), a strongly staining AMRP-positive neuron was
observed in the E cluster at the base of the cerebrobuccal connective.
Dense immunostained processes were seen throughout the neuropil of the
cerebral ganglion, and immunostained axons were observed in all the
cerebral nerves. A particularly high density of immunostained axons was
observed in the cerebropleural connective, and a particularly large,
intensely staining axon was observed in the cerebropedal connective.
This fiber could be traced into the cerebral neuropil and was observed
to cross to the opposite hemiganglion via the cerebral commissure.

View larger version (56K):
[in this window]
[in a new window]
|
Figure 7.
AMRP neurons in the cerebral ganglion.
A1, In situ hybridization of dorsal
surface. A2, Immunocytochemistry of dorsal surface.
A3, Drawing of the AMRP neurons on the dorsal cerebral
ganglion. B1, In situ hybridization of
ventral surface. B2, Immunocytochemistry of ventral
surface. B3, Drawing of the AMRP neurons on the ventral
cerebral ganglion. UL, Upper labial nerve;
PT, posterior tentacular nerve; ON, optic
nerve; AT, anterior tentacular nerve; LL,
lower labial nerve; CBC, cerebrobuccal connective;
CPe, cerebropedal connective; CPl,
cerebropleural connective. Scale bar: A1, 500 µm (same
in all panels).
|
|
Pleural ganglion (Fig. 8)
The highest concentration of AMRP-positive neurons were in the
pleural ganglia, with right and left pleural ganglia showing different
staining patterns. In the left pleural ganglion, the giant cell (LP1)
and several large neurons (150-200 µm) in a cluster around the
pleuroabdominal connective were AMRP-positive. This cluster extended
along the anterior part of the ganglion on both the dorsal and ventral
surfaces. In the right pleural ganglion, a similar cluster of
AMRP-positive neurons (100-200 µm) was observed in the anterior part
of the ganglion between the pleuroabdominal connective and the
pleurocerebral connective. This cluster also extended from the dorsal
to the ventral aspect of the anterior part of the ganglion, but
contained more smaller AMRP-positive neurons (100 µm). These neurons
were examined by MALDI-TOF analysis to independently confirm that they
contain the AMRPs. The dorsal surface of right pleural ganglion
contained a large number (~50) of smaller (50-80 µm) AMRP-positive
neurons near the pleuropedal connective. Immunostained processes were
observed in the neuropil of both ganglia, and immunostained axons were
observed in all the pleural nerves.

View larger version (119K):
[in this window]
[in a new window]
|
Figure 8.
AMRP neurons in the pleural and pedal ganglia.
A1, In situ hybridization of left
ganglion pair dorsal surface. A2,
Immunocytochemistry of the left ganglion pair dorsal surface.
A3, Drawing of the AMRP neurons on the dorsal surface of
the left ganglion pair. B1, In situ
hybridization of left ganglion pair ventral surface. B2,
Immunocytochemistry of the left ganglion pair ventral surface.
B3, Drawing of the AMRP neurons on the ventral surface
of the left ganglion pair. C1, In situ
hybridization of right ganglion pair dorsal surface. C2,
Immunocytochemistry of the right ganglion pair dorsal surface.
C3, Drawing of the AMRP neurons on the dorsal surface of
the right ganglion pair. D1, In situ
hybridization of right ganglion pair ventral surface.
D2, Immunocytochemistry of the right ganglion pair
ventral surface. D3, Drawing of the AMRP neurons on the
ventral surface of the right ganglion pair. L, Pleural
ganglion; E, pedal ganglion; LE,
pleuropedal connective; EE, pedal commissure;
EC, cerebropedal connective; LC,
cerebropleural connective; LA, pleuroabdominal
connective; E5, posterior tegumentary nerve (P5);
E6, anterior parapodial nerve (P6); E9,
posterior pedal nerve (P9). Not all nerves are drawn for simplicity.
Scale bar: A1, 500 µm (same in all panels).
|
|
Pedal ganglion (Fig. 8)
The pedal ganglion had the lowest concentration of AMRP-positive
neurons. Typically only one or two AMRP-positive neurons were observed
on the ventral surface near the pleuropedal connective. Dense
immunostained processes in the pedal neuropil and
immunostained axons could be observed in most of the pedal nerves.
Abdominal ganglion (Fig. 9)
The abdominal ganglion also showed a high concentration of
AMRP-positive neurons. On the dorsal surface (Fig. 9A1-3),
the giant neuron R2 and several smaller neurons in its immediate
vicinity were AMRP-positive. In the left hemiganglion, a cluster of
AMRP-positive neurons is located at the base of the genital pericardial
and siphon nerves. This cluster extended around the medial aspect of
the left ganglion dorsally to almost encircle the genital pericardial nerve. Most of these neurons were of medium size, ~100 µm, with a
single larger (~300 µm) neuron at the ventrolateral aspect of this
cluster. There was also a strongly staining AMRP-positive cluster of
100-200 µm neurons in the right ventral hemiganglion located near
the pleuroabdominal connective (Fig. 9B1-3). MALDI-TOF MS
of neurons from these regions confirms the presence of all the AMRPs
(data not shown). Numerous immunostained axons were observed in all the
nerves exiting the abdominal ganglion. The sheath overlying the bag
cells showed a dense immunostained innervation, but no immunostained
processes were observed on the bag cell bodies themselves (Fig.
9B2, inset). This innervation suggests that
AMRPs may affect the bag cells and/or their processes.

View larger version (54K):
[in this window]
[in a new window]
|
Figure 9.
AMRP neurons in the abdominal ganglion.
A1, In situ hybridization of dorsal
surface. A2, Immunocytochemistry of dorsal surface.
A3, Drawing of the AMRP neurons on the dorsal abdominal
ganglion. B1, In situ hybridization of
ventral surface. B2, Immunocytochemistry of ventral
surface. Inset is the same region as
arrow, partially desheathed bag cells from an adult
animal showing dense immunopositive innervation of the sheath overlying
the bag cells, but not the bag cells themselves. B3,
Drawing of the AMRP neurons on the ventral abdominal ganglion.
LC, Left pleuroabdominal connective; RC,
right pleuroabdominal connective; VN, vulvar nerve;
BN, branchial nerve; STN, spermathecal
nerve; PN, pericardial nerve; GN, genital
nerve; SN, siphon nerve. Scale bar: A1,
500 µm (same in all panels, including
inset).
|
|
Body wall (Fig.
10A)
Sparse immunopositive innervation was observed in the body wall,
but none was observed in the foot. The immunopositive innervation was
not uniformly distributed throughout the body wall, but was concentrated in restricted areas. Immunopositive axons were also observed in many of the nerves innervating the body wall.

View larger version (138K):
[in this window]
[in a new window]
|
Figure 10.
AMRP immunocytochemistry in cardiovascular system
and other peripheral tissues. A, Body wall musculature
(200 gm animal). B, Anterior aorta (10 gm animal).
C, Abdominal aorta (10 gm animal). D,
Gastrointestinal artery (10 gm animal). E, Pericardium
(10 gm animal). F, Heart valves with heart at
right, crista aortae at left, and
abdominal aorta at bottom (10 gm animal).
G, Crista aortae at bottom and
pericardium (10 gm animal). H, Gill (10 gm animal).
Scale bar: A, 500 µm (same in all panels).
|
|
Buccal mass
The buccal mass is a collection of muscles that control the
movements of the radula, a cartilaginous structure that, in turn, controls the movement of food into the animal. We found no
immunopositive innervation in either the entire buccal mass from a 10 gm animal or selected muscles from larger animals (data not shown).
This suggests that none of the motor or sensory neurons that innervate the buccal musculature express these neuropeptides. The buccal ganglion
innervates the buccal mass, and immunopositive axons were observed only
in nerves that innervate the region of the esophagus which, as
described below, is strongly immunopositively innervated.
Circulatory and respiratory systems
(Fig. 10B-G)
Aplysia has an open circulatory system containing a
single atrium and ventricle (Kandel, 1979 ; Skelton et al., 1992 ). Three major arteries, the anterior, the gastrointestinal, and the abdominal arteries, direct blood flow to different parts of the animal. In the
cardiovascular system, no immunoreactivity was observed in the heart.
In contrast, dense immunoreactive innervation was evident in
pericardium as well as all the major arteries. The innervation was
observed in the proximal arterial system, and was not evident in
distal, smaller branches of the arterial system. Because most of the
neurons responsible for cardiovascular control reside in the abdominal
ganglion, it is reasonable to assume that the AMRP-immunopositive
neurons innervating the major arteries reside in the abdominal
ganglion. Immunopositive innervation was also detected in the gill
(Fig. 10H) and kidney (data not shown) of the animal,
both of which are heavily vascularized. The dense proximal
immunopositive innervation of the proximal arterial system suggests
that the AMRPs may be involved in vascular tone and redirection of
blood flow (Skelton et al., 1992 ).
Reproductive system (Fig.
11A-H)
Aplysia is a hermaphrodite containing both male and
female reproductive organs (Blankenship et al., 1977 ; Kandel, 1979 ;
Painter et al., 1985 ). In the male reproductive system, the penis is
housed inside the animal, but is everted during copulation. The
position of the penis is controlled by two extrinsic penis retractor
muscles, extrinsic penis extensor muscles, and longitudinal muscles in the penis sheath. Immunopositive innervation was detected in all these
muscles, but was particularly dense in the penis sheath (Fig.
11A,B). Occasionally, small (10-20 µm)
immunopositive neurons could be seen along the nerve running
adjacent to the penis sheath.

View larger version (144K):
[in this window]
[in a new window]
|
Figure 11.
AMRP immunostaining in the reproductive system.
A, Penis retractor muscle. B, Penis
sheath. C, Large hermaphroditic duct. D,
Small hermaphroditic duct. E, Junction of small
hermaphroditic duct (top right), large hermaphroditic
duct (bottom right), seminal receptacle (bottom
left), and accessory genital mass (top left).
F, As in E but viewed from the other side
with seminal receptacle more in focus on bottom right.
G, Accessory genital mass. H, Spermatheca
(gametolytic gland) surrounded by pericardium. All panels from sexually
mature 100 gm animal. Scale bar: A, 500 µm (same in
all panels).
|
|
The female portion of the reproductive system of the animal is also
densely immunopositively innervated (Fig. 11C-H). In
addition, numerous immunopositive neuronal soma were observed.
Approximately 50-100 immunopositive neurons were observed in the large
hermaphroditic duct (Fig. 11C), and 10-20 immunopositive
neurons were observed in the small hermaphroditic duct (Fig.
11D) (near the entry point to the accessory genital
mass). The small hermaphroditic duct was densely innervated with
immunopositive fibers, especially near the entry point to the accessory
genital mass. These fibers were radial in appearance, forming rib-like
structures. Immunopositive innervation could also be seen in the
accessory genital mass (Fig. 11G), spermatheca (also called
the gametolytic gland; Fig. 11H), seminal receptacle
(Fig. 11F), and large hermaphroditic duct. The far-ranging innervation of AMRP-immunopositive neurons throughout the
reproductive system suggests that these peptides have important roles
in its function. Additional effects of these peptides on reproduction
may be exerted on the bag cells and/or their processes in the abdominal ganglion.
Digestive system (Fig. 12)
Of all the peripheral tissues examined immunohistochemically, the
most striking pattern was observed in the anterior digestive tract. The
digestive tract of Aplysia consists of the esophagus, the
crop, the triturating stomach (anterior gizzard), the filtering chamber
(posterior gizzard), intestine (true stomach), and the rectum (Kandel,
1979 ; Lloyd et al., 1988 ). Immunostained enteric neurons were observed
in a ring-like structure, which we are calling the stomatogastric ring,
at the junction of the crop and triturating stomach (Fig.
12E). Small cardioactive peptide (SCP)-immunostaining neurons were previously reported in this structure (Lloyd et al., 1988 ). Additional immunopositive neurons were observed throughout the
filtering chamber and posterior crop (Fig.
12B,D,F). Few immunopositive enteric neurons
were detected in the triturating stomach, and no immunopositive neurons
were observed in the esophagus (Fig. 12A). In
situ hybridization-positive neurons were detected with the same
distribution in these structures, confirming the specificity of the
immunostaining (Fig. 12G,H). A dense network of
immunopositive fibers was observed throughout the anterior digestive
tract, including the esophagus (Fig. 12A), crop (Fig.
12B), triturating stomach (Fig. 12C), and
filtering chamber (Fig. 12D,F). In contrast,
the posterior part of the digestive tract, which is embedded in the
hepatopancreas (including the true stomach, intestine, and cecum) is
virtually devoid of immunostained neurons and processes (data not
shown). The extensive innervation of the anterior part of digestive
tract by AMRP-immunopositive neurons suggests that these peptides are exerting important effects in its function.

View larger version (159K):
[in this window]
[in a new window]
|
Figure 12.
AMRP immunostaining and in situ
hybridization in the digestive system. A, Esophagus
immunostaining (10 gm animal). B, Crop immunostaining
(10 gm animal). C, Triturating stomach immunostaining
(10 gm animal). D, Filtering chamber immunostaining (200 gm animal). E, Stomatogastric ring immunostaining (10 gm
animal). F, Filtering chamber immunostaining (10 gm
animal). G, Stomatogastric ring in situ
(10 gm animal). H, Filtering chamber in
situ (10 gm animal). Scale bar: A, 500 µm
(same in all panels).
|
|
Physiological actions of AMRPs on Aplysia muscles
To obtain more physiological evidence that the peptides act as
signaling molecules, we examined effects of the peptides on mechanical
responses of some of the immunopositive tissues, including the
esophagus, penis retractor muscle, and body wall muscle in A. kurodai.
Esophagus
The isolated esophagus showed complex pattern of contractions for
more than several hours. Application of AMRPs caused significant suppression of the spontaneous contraction of the esophagus in a
dose-dependent, reversible manner (Fig.
13). Figure 13A shows a
representative suppression by GAPRFIamide. It is notable that the
effects of the five isoforms that were biochemically isolated from the
CNS were qualitatively similar, but the potency was slightly different
from each other (Fig. 13B). The most potent isoform was GAPRFVamide, and the least potent one was GSPRFFamide; the potency difference between the two peptides was about one order of magnitude. Subsequently, another nine peptides that were predicted from the cDNA
sequence were chemically synthesized, and their effects were examined.
Seven of the nine showed inhibitory effects almost comparable to the
above five purified peptides (Fig. 13C). However,
LWVPGMVamide and SDPFFMamide were over two orders of magnitude less
potent than the above seven peptides (Fig. 13C).

View larger version (34K):
[in this window]
[in a new window]
|
Figure 13.
Effect of AMRPs on contractions of the esophagus
of Aplysia. A, Dose-dependent inhibition of the
esophagus motility by GAPRFIamide. B, Dose-response
relationship for the five purified AMRPs. , GAPRFVamide; ,
GAPRFIamide; , GPPRFIamide; , GSPHFIamide; , GSPRFFamide.
C, Dose-response relationship for the nine predicted
AMRPs. , GAAPKFFamide; , GQAPRFIamide; , AMAPKFFamide; ,
AAPRFFamide; , QAPRFFamide, , SDPFFMamide; , GAPRFLamide; ,
QAPRFIamide; , LWVPGMVamide. Note that LWGPGMamide and SDPFFMamide
were much less potent than the others.
|
|
Penis retractor muscle
Figure 14A shows
the inhibitory effect of the AMRPs on electrically induced tetanic
contraction of the penis retractor muscle at
10 8 M. The order
of potency was different from that in the case of the esophagus;
GAPRFIamide and GPPRFIamide were more potent than the others.
SDPFFMamide and LWVPGMVamide, which were much less effective than the
other AMRPs on the esophagus, showed significant inhibition comparable
to one of the authentic isoforms, GSPHFIamide and GSPRFFamide.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 14.
Effect of AMRPs on contractions of other muscles
in Aplysia. A, Effect on electrically induced
contraction of the penis retractor muscle. Repetitive electrical pulses
(20 V, 1 msec, 40 Hz, 40 pulses) were applied to the muscle at 10 min
intervals. Peptides (10 8 M) were
applied for 9 min. B, Effect on electrically induced
contraction of the dorsal longitudinal muscle of the body wall.
Electrical pulses (20 V, 2 msec, 100 Hz, 20 pulses) were applied at 10 min intervals. Peptides (10 7 M were
applied for 9 min.
|
|
Body wall muscle
Contraction of the body wall muscle was also suppressed by the
AMRPs (Fig. 14B). GAPRFVamide was again most
effective among the isoforms tested. However, the order of potency of
each peptide was different from those in the cases of the other
muscles, and GSPHFIamide and LWVPGMVamide were ineffective at
10 7 M.
 |
DISCUSSION |
In this paper, we describe the isolation of five peptides from the
opisthobranch mollusc Aplysia kurodai. They were homologous to the MIP-family peptides and thus named AMRPs. Based on the sequence
of these peptides, we cloned a cDNA encoding the AMRP precursor protein
from a closely related species, Aplysia californica. This is
the first report on the MIP-related peptides in the opisthobranch gastropods and the first demonstration of the precursor structure for
the MIP-related peptides. The precursor contained 26 copies of 14 different amidated AMRPs, including the five purified peptides. The
expression of these AMRPs was confirmed by MALDI-TOF MS. In addition,
two of the AMRP peptides are N-terminally modified to pyroglutamate.
Amidation is often indicative of bioactive peptides. In fact, the
C-terminal amidation is required for bioactivity of a number of
different peptides (Eipper et al., 1992 ). Mass spectra from the pleural
neurons also indicated the presence of some of the connecting peptides
predicted by the precursor.
In addition to sharing structural features with MIPs, the
AMRPs share some structural and functional features with the
vertebrate opioid peptides. In particular, 17 of 26 AMRPs end in
PXFFamide (where X is a basic residue), which is similar to the
recently discovered mammalian putative µ opiate receptor ligand
neuropeptide endomorphin 2 (YPFFamide; Zadina et al., 1997 ).
Furthermore, two other AMRPs, SDPFFMamide and GAPRFLamide share the
same two C-terminal amino acids as Met (YGGFM) and Leu
(YGGFL) enkephalin, respectively (Harrison et al., 1998 ). There have
been several reports of Leu and Met enkephalin-like peptides in
Aplysia based on immunocytology, ligand binding, and
physiological responses, but no amino acid sequences for these peptides
in Aplysia have been reported (Lukowiak et al., 1982 ; Leung
et al., 1986 ; Takayanagi and Takeda, 1988 ; Carpenter et al., 1995 ). The
AMRPs may be some of the endogenous ligands in
Aplysia that account for these observations. For example, one of the AMRPS, SDPFFMamide, may be an endogenous ligand for the
high-affinity binding site of
D-Ala2-Met-enkephalinamide
(YdAGFMamide) that has been described (Carpenter et al., 1995 ). The
AMRPs also share some functional features with opioid peptides in
mammals. These include an inhibitory action on contractions of the
digestive tract and presence in the reproductive system. In addition,
the AMRPs are expressed at high levels in the pleural and abdominal
ganglia, which contain the neurons controlling respiration and
cardiovascular regulation, well known targets of opiate actions in
mammals (Olson et al., 1998 ). Because the precursor to endomorphin-2
has not yet been published, it remains to be determined whether the
similarities between AMRPs and these opioid peptides is functional or
merely coincidental.
The bioactivity of MIPs in other species has, in general, been found to
be inhibitory (Yongsiri et al., 1989 ; Kiss, 1990 ; Li et al., 1996 ; Kiss
and Osipenko, 1997 ). We found that the AMRPs were also inhibitory on
three Aplysia target muscles. Two important points emerge
from these studies. First, the different peptides on the AMRP precursor
have different dose-response relationships on one target. Differences
in potency of different peptides arising from the same precursor has
been documented in other systems (Cropper et al., 1994 ; Vilim et al.,
1994 ; Brezina et al., 1995 ; van Golen et al., 1996 ; Hewes et al., 1998 ;
Perry et al., 1998 ). Curiously, some of the structurally related
peptides derived from a single precursor appear to lack bioactivity
altogether when examined on single targets. Second, the rank order of
the potency of different AMRPs is different among distinct targets.
Different rank orders of potencies of the peptide products of a single
precursor on different targets has been shown for allostatins in
insects (Bendena et al., 1997 ) and for POMC in mammals. However, these
peptides are released into the blood, thus are more endocrine in
function, and their targets are more diverse. Here we show that for
similar targets, the modulatory peptide products derived from a single precursor show differing rank orders of potencies.
Our results suggest that the different peptides produced from a single
precursor are not simply functionally redundant. For example, peptides
that apparently lack bioactivity on one target could possess
bioactivity on other targets. If different receptor subtypes account
for different rank orders of potencies, then the combination of
receptors that the released peptide milieu encounters could determine
its actions. Conversely, the combination of receptors expressed by a
target could determine the response characteristics to the same peptide
milieu released on it. In the case of different targets of the same
neuron, differences in receptor expression could increase the diversity
of response to the same range of peptide release. Furthermore,
differential expression of peptidases in various tissues could also
affect the rank order of peptide potencies. This underscores the
importance of identifying the complement of bioactive peptides that are
released from neurons of interest, because the actions of single
peptides may yield erroneous interpretations of their function.
Clearly, complementary multidisciplinary approaches are needed to
obtain a more accurate understanding of the physiological function of modulatory peptide transmitters.
The peptides contained on the AMRP precursor may have an important role
in the function of many systems, including the digestive tract. In
fact, MIP-related peptides inhibit contractions of the digestive tract
in other molluscan species (Li et al., 1996 ). Several lines of evidence
conclusively demonstrate that these peptides are present in the gut of
Aplysia. First, one of the peptides contained on the AMRP
precursor, GAPRFVamide, was biochemically isolated from extracts of the
gut based on its inhibitory actions on contractions. Second, neurons in
the gut have been shown to contain mRNA coding for AMRPs using in
situ hybridization. Third, immunocytochemistry indicates dense
immunopositive innervation and many AMRP immunopositive neurons in the
gut. Finally, AMRPs profoundly inhibit contractions of the gut.
In addition to innervating the gut, AMRP-containing processes also
innervate a group of buccal neurons, the B1-B2 cluster that regulates
gut motility (Lloyd et al., 1988 ). Because multiple AMRP-immunopositive
axons are present in the esophageal nerve, which connects the gut with
the buccal ganglion, the AMRP containing innervation of the B1-B2
cluster may originate in AMRP neurons of the gut. Thus, the AMRPs may
be acting both locally in the gut and centrally in the buccal ganglion
to regulate the contractions of the digestive tract. Because many
neurons that have axons in the cerebrobuccal connective have been shown
to be a part of the circuitry responsible for generating feeding in
Aplysia, the presence of AMRP-immunopositive axons in these
connectives also suggests a function of AMRPs in the feeding behavior
of Aplysia. One of the AMRPs, GAPRFVamide, has also been
detected in the buccal nerves and esophagus of Lymnaea (Li
et al., 1996 ), suggesting that MIP-related peptides may have similar
functions in other gastropods.
In addition to functioning in the digestive system, the AMRPs may also
have important functions in other systems of Aplysia. The
presence of dense AMRP-immunopositive innervation in both the male and
female reproductive systems suggests that these peptides have important
roles in their function. The inhibitory actions of AMRPs on
contractions of the penis retractor muscle support this notion.
Although variable, AMRP-containing innervation is apparently present
throughout the reproductive system. The source of this innervation
appears, at least in part, to be of local origin because immunopositive
neurons are present in these structures. However, it is likely that at
least some of the immunopositive innervation arises from as yet
unidentified AMRP neurons in the CNS. The presence of dense
AMRP-immunopositive innervation in the sheath covering the bag cells
suggests that these peptides may exert effects on the central
neuroendocrine control of the reproductive system and/or be released
into the hemolymph and have endocrine functions.
Another system in which AMRPs are likely to exert important effects is
in cardiovascular control. Although no innervation was detected in the
heart, dense immunopositive innervation was detected in the major
arteries, pericardium, and the highly vascularized kidney and gill. The
vascular innervation is likely to originate in the abdominal ganglion
because most of the neurons involved in cardiovascular regulation are
located in this ganglion (Skelton et al., 1992 ), and the AMRPs are
abundantly expressed in the abdominal ganglion. Preliminary results
(data not shown) indicate that AMRPs relax the vascular muscle and
suggest that these peptides could redirect blood flow. Thus, AMRPs may
serve a similar function in Aplysia as endothelin does in
vertebrate vasculature. The abundant expression of AMRPs in the
abdominal and pleural ganglia, as well as the dense immunopositive
innervation in the gill suggests that these peptides may play a role in
the plasticity associated with the gill withdrawal reflex (Kandel,
1979 ; Lukowiak et al., 1982 ).
We have demonstrated the presence of the AMRPs and the mRNA that codes
for their precursor protein in the CNS and in peripheral tissues of
Aplysia. Evidence for their presence in the innervation of
multiple peripheral targets suggests that these peptides may function
in many systems, including feeding, reproduction, circulation, respiration, excretion, and locomotion. Future work is likely to show
that these peptides are important modulators in many of these systems.
 |
FOOTNOTES |
Received May 5, 1999; revised Aug. 16, 1999; accepted Aug. 16, 1999.
This work was supported by a Grant-in-Aid from the Ministry of
Education, Science, Sports, and Culture of Japan to Y. Fujisawa, Y. Furukawa, and O. Matsushima. Y. Furukawa was also supported by the
Suntory Institute for Bioorganic Research and a traveling grant from
the Brain Science Foundation. The support of the National Institute of
Neurological Diseases and Stroke through Grant NS31609 to J.V.S. and
the National Institute of Mental Health through Grants MH50235 and
K05MH01427 to K.R.W. is gratefully acknowledged. We are grateful to
Drs. M. Kurokawa (Tokyo Metropolitan University, Tokyo, Japan) and T. Nagahama (Kobe University, Kobe, Japan) for supplying the animals and
to Dr. Gregg Nagle for the generous gift of the Aplysia
cDNA library. Aplysia californica were partially provided by the National Resource for Aplysia at the
University of Miami under National Institutes of Health National Center
for Research Resources Grant RR10294.
Correspondence should be addressed to Ferdinand S. Vilim, Box 1218, Department of Physiology and Biophysics, Mount Sinai School of
Medicine, New York, NY 10029. E-mail: vilim{at}inka.mssm.edu.
 |
REFERENCES |
-
Bendena WG,
Garside CS,
Yu CG,
Tobe SS
(1997)
Allatostatins: diversity in structure and function of an insect neuropeptide family.
Ann NY Acad Sci
814:53-66[Medline].
-
Blankenship JE,
Rock MK,
Hill J
(1977)
Physiological properties of the penis retractor muscle of Aplysia.
J Neurobiol
8:549-568[Web of Science][Medline].
-
Brezina V,
Bank B,
Cropper EC,
Rosen S,
Vilim FS,
Kupfermann I,
Weiss KR
(1995)
Nine members of the myomodulin family of peptide cotransmitters at the B16-ARC neuromuscular junction of Aplysia.
J Neurophysiol
74:54-72[Abstract/Free Full Text].
-
Brezina V,
Orekhova IV,
Weiss KR
(1996)
Functional uncoupling of linked neurotransmitter effects by combinatorial convergence.
Science
273:806-810[Abstract].
-
Campanelli JT,
Scheller RH
(1987)
Histidine-rich basic peptide: a cardioactive neuropeptide from Aplysia neurons R3-14.
J Neurophysiol
57:1201-1209[Abstract/Free Full Text].
-
Carpenter DO,
Kemenes G,
Elekes K,
Leung M,
Stefano G,
Rozsa KS,
Salanki J
(1995)
Opioid peptides in the nervous system of Aplysia: a combined biochemical, immunocytochemical, and electrophysiological study.
Cell Mol Neurobiol
15:239-256[Web of Science][Medline].
-
Chomcyznski P,
Sacchi N
(1987)
Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:156-159[Web of Science][Medline].
-
Cropper EC,
Brezina V,
Vilim FS,
Harish O,
Price D,
Rosen S,
Kupfermann I,
Weiss KR
(1994)
FRF peptides in the ARC neuromuscular system of Aplysia: purification and physiological actions.
J Neurophysiol
72:2181-2195[Abstract/Free Full Text].
-
de With ND,
Li KW,
Jimenez CR,
Vnok N,
Dreisewerd K,
Hillenkamp F,
Karas M,
Geraerts WPM
(1997)
Intracellular degradation of C-peptides in molluscan neurons producing insulin-related hormones.
Peptides
18:765-770[Web of Science][Medline].
-
Eipper BA,
Stoffers DA,
Mains RE
(1992)
The biosynthesis of neuropeptides: peptide alpha-amidation.
Annu Rev Neurosci
15:57-85[Web of Science][Medline].
-
Fan X,
Croll RP,
Wu B,
Fang L,
Shen Q,
Painter SD,
Nagle GT
(1997)
Molecular cloning of a cDNA encoding the neuropeptides APGWamide and cerebral peptide 1: location of APGWamide-like immunoreactivity in the central nervous system and male reproductive organs of Aplysia.
J Comp Neurol
387:53-62[Web of Science][Medline].
-
Floyd PD,
Li L,
Moroz TP,
Sweedler JV
(1999)
Characterization of peptides from Aplysia using microbore liquid chromatography with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry guided purification.
J Chromatogr A
830:105-113[Web of Science][Medline].
-
Fujisawa Y
(1996)
Immunohistochemical localization and Ca2+-dependent release of Mytilus inhibitory peptides in the ABRM of Mytilus edulis.
Zool Sci
13:795-801.
-
Fujisawa Y,
Kubota I,
Ikeda T,
Minakata H,
Muneoka Y
(1991)
A variety of Mytilus inhibitory peptides in the ABRM of Mytilus edulis: isolation and characterization.
Comp Biochem Physiol
100C:525-531.
-
Fujisawa Y,
Takahashi T,
Ikeda T,
Muneoka Y,
Kubota I,
Minakata H,
Nomoto K,
Nose T,
Miki W
(1993)
Further identification of bioactive peptides in the anterior byssus retractor muscle of Mytilus: two contractile and three inhibitory peptides.
Comp Biochem Physiol
106C:261-267.
-
Garden RW,
Moroz LL,
Moroz TP,
Shippy SA,
Sweedler JV
(1996)
Excess salt removal with matrix rinsing: direct profiling of neurons from marine invertebrates using MALDI-TOF mass spectrometry.
J Mass Spectrom
31:1126-1130[Web of Science][Medline].
-
Garden RW,
Shippy SA,
Li L,
Moroz TP,
Sweedler JV
(1998)
Proteolytic processing of the Aplysia egg-laying hormone prohormone.
Proc Natl Acad Sci USA
95:3972-3977[Abstract/Free Full Text].
-
Harrison LM,
Kastin AJ,
Zadina JE
(1998)
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates.
Peptides
19:1603-1630[Web of Science][Medline].
-
Hewes RS,
Snowdeal III EC,
Saitoe M,
Taghert PH
(1998)
Functional redundancy of FMRFamide-related peptides at the Drosophila larval neuromuscular junction.
J Neurosci
18:7138-7151[Abstract/Free Full Text].
-
Hirata T,
Kubota I,
Iwasawa N,
Takabatake I,
Ikeda T,
Muneoka Y
(1988)
Structures and actions of Mytilus inhibitory peptides.
Biochem Biophys Res Commun
152:1376-1382[Web of Science][Medline].
-
Ikeda T,
Y-Kamatani Y,
Minakata H,
Kenny PTM,
Nomoto K,
Muneoka Y
(1992a)
Mytilus-inhibitory peptide analogues isolated from the ganglia of a pulmonate mollusc, Achatina fulica.
Comp Biochem Physiol
101C:245-249.
-
Ikeda T,
Minakata H,
Fujita T,
Muneoka Y,
Kiss T,
Hiripi L,
Nomoto K
(1992b)
Neuropeptides isolated from Helix pomatia Part 1. Peptides related to MIP, buccalin, myomodulin-CARP and SCP.
In: Peptide chemistry 1992 (Yanaihara N,
ed), pp 576-578. Osaka: ESCOM.
-
Jahan-Parwar B,
Fredman SM
(1976)
Cerebral ganglion of Aplysia: cellular organization and origin of nerves.
Comp Biochem Physiol
54A:347-357.
-
Jimenez CR,
van Veelen PA,
Li KW,
Wildering WC,
Geraerts WPM,
Tjaden UR,
van der Greef J
(1994)
Neuropeptide expression and processing as revealed by direct matrix-assisted laser desorption ionization mass spectrometry of single neurons.
J Neurochem
62:404-407[Web of Science][Medline].
-
Kandel ER
(1979)
In: Behavioral biology of Aplysia. San Francisco: W. H. Freeman.
-
Kaufmann R,
Spengler B,
Lutzenkirchen F
(1993)
Mass spectrometric sequencing of linear peptides by product-ion analysis in a reflectron time-of-flight mass spectrometer using matrix-assisted laser desorption ionization.
Rapid Commun Mass Spectrom
7:902-910[Web of Science][Medline].
-
Kiss T
(1990)
Effect of Mytilus inhibitory peptide on identified molluscan neurons.
Comp Biochem Physiol
95C:207-212.
-
Kiss T,
Osipenko ON
(1997)
Effects of molluscan neuropeptide RAPYFVamide on identified Helix pomatia L. neurons.
Gen Pharmacol
29:97-102[Web of Science][Medline].
-
Leung MK,
Rozsa KS,
Hall A,
Kuruvilla S,
Stefano GB,
Carpenter DO
(1986)
Enkephalin-like substance in Aplysia nervous tissue and actions of leu-enkephalin on single neurons.
Life Sci
38:1529-1534[Web of Science][Medline].
-
Li KW,
Van Minnen J,
Van Veelen PA,
Van der Greef J,
Geraertss WPM
(1996)
Structure, localization and action of a novel inhibitory neuropeptide involved in the feeding of Lymnaea.
Mol Brain Res
37:267-272[Medline].
-
Li L,
Moroz TP,
Garden RW,
Floyd PD,
Weiss KR,
Sweedler JV
(1998)
Mass spectrometric survey of interganglionically transported peptides in Aplysia.
Peptides
19:1425-1433[Web of Science][Medline].
-
Lloyd PE,
Kupfermann I,
Weiss KR
(1988)
Central peptidergic neurons regulate gut motility in Aplysia.
J Neurophysiol
59:1613-1625[Abstract/Free Full Text].
-
Lukowiak K,
Thornhill JA,
Edstrom J
(1982)
Methionine enkephalin increases CNS suppressive control exerted over gill reflex behaviours and associated neural activity in Aplysia california.
Regul Pept
3:303-312[Web of Science][Medline].
-
Makabe KW,
Fujiwara S,
Nishida H,
Satoh N
(1992)
Failure of muscle myosin heavy-chain gene expression in quarter ascidian embryos developed from the secondary muscle lineage cells.
Zool Sci
9:569-573.
-
Nielsen H,
Engelbrecht J,
Brunak S,
von Heijne G
(1997)
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.
Protein Engineering
10:1-6[Abstract/Free Full Text].
-
Ohtani M,
Muneoka Y,
Takahashi T,
Teranishi H
(1995)
Bioactive peptides isolated from the clam Meretrix lusoria.
Acta Biol Hung
46:2-4.
-
Olson GA,
Olson RD,
Vaccarino AL,
Kastin AJ
(1998)
Endogenous opiates: 1997.
Peptides
19:1791-843[Web of Science][Medline].
-
Painter SD,
Kalman VK,
Nagle GT,
Zuckerman RA,
Blankenship JE
(1985)
The anatomy and functional morphology of the large hermaphroditic duct of three species of Aplysia, with special reference to the atrial gland.
J Morphol
186:167-194[Web of Science][Medline].
-
Perry SJ,
Straub VA,
Kemenes G,
Santama N,
Worster BM,
Burke JF,
Benjamin PR
(1998)
Neural modulation of gut motility by myomodulin peptides and acetylcholine in the snail Lymnaea.
J Neurophysiol
79:2460-2474[Abstract/Free Full Text].
-
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
In: Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor.
-
Scheller RH,
Jackson JF,
McAllistar LB,
Rothman BS,
Mayer E,
Axel R
(1983)
A single gene encodes multiple neuropeptides mediating a stereotyped behavior.
Cell
32:7-22[Web of Science][Medline].
-
Sediah NG,
Chreiten M
(1997)
Eukaryotic protein processing: endoproteolysis of precursor proteins.
Curr Opin Biotechnol
8:602-607[Web of Science][Medline].
-
Skelton M,
Alevizos A,
Koester J
(1992)
Control of the cardiovascular system of Aplysia by identified neurons.
Experientia
48:809-817[Web of Science][Medline].
-
Spengler B
(1997)
Post-source decay analysis in matrix-assisted laser desorption/ionization mass spectrometry of biomolecules.
J Mass Spectrom
32:1019-1036.
-
Takayanagi H,
Takeda N
(1988)
Coexistence of FMRFamide, met-enkephalin and serotonin in molluscan neurons.
Comp Biochem Physiol A
91:613-620[Medline].
-
van Golen FA,
Li KW,
Chen S,
Jimenez CR,
Geraerts WP
(1996)
Various isoforms of myomodulin identified from the male copulatory organ of Lymnaea show overlapping yet distinct modulatory effects on the penis muscle.
J Neurochem
66:321-329[Web of Science][Medline].
-
Vilim FS,
Cropper EC,
Rosen SC,
Tenenbaum R,
Kupfermann I,
Weiss KR
(1994)
Structure, cellular localization and modulatory action of buccalin b-a novel bioactive peptide from Aplysia californica.
Peptides
15:959-969[Web of Science][Medline].
-
Vilim FS,
Price DA,
Lesser W,
Kupfermann I,
Weiss KR
(1996a)
Costorage and corelease of modulatory peptide cotransmitters with partially antagonistic actions on the accessory radula closer muscle of Aplysia californica.
J Neurosci
16:8092-8104[Abstract/Free Full Text].
-
Vilim FS,
Cropper EC,
Price DA,
Kupfermann I,
Weiss KR
(1996b)
Release of peptide cotransmitters in Aplysia: regulation and functional implications.
J Neurosci
16:8105-8114[Abstract/Free Full Text].
-
Worster BM,
Yeoman MS,
Benjamin PR
(1998)
Matrix-assisted laser desorption/ionization time of flight mass spectrometric analysis of the pattern of peptide expression in single neurons resulting from alternative mRNA splicing of the FMRFamide gene.
Eur J Neurosci
10:3498-3507[Web of Science][Medline].
-
Yongsiri A,
Takeuchi H,
Kubota I,
Muneoka Y
(1989)
Effects of Mytilus inhibitory peptides on a giant neurone of Achatina fulica Ferussac.
Eur J Pharmacol
171:159-165[Web of Science][Medline].
-
Zadina JE,
Hackler L,
Ge LJ,
Kastin AJ
(1997)
A potent and selective endogenous agonist for the µ-opiate receptor.
Nature
386:499-502[Medline].
Copyright © 1999 Society for Neuroscience 0270-6474/99/19219618-17$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Gupta, F. M. Decaillot, I. Gomes, O. Tkalych, A. S. Heimann, E. S. Ferro, and L. A. Devi
Conformation State-sensitive Antibodies to G-protein-coupled Receptors
J. Biol. Chem.,
February 23, 2007;
282(8):
5116 - 5124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Proekt, F. S. Vilim, V. Alexeeva, V. Brezina, A. Friedman, J. Jing, L. Li, Y. Zhurov, J. V. Sweedler, and K. R. Weiss
Identification of a New Neuropeptide Precursor Reveals a Novel Source of Extrinsic Modulation in the Feeding System of Aplysia
J. Neurosci.,
October 19, 2005;
25(42):
9637 - 9648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sasaki, F. Morishita, and Y. Furukawa
Peptidergic innervation of the vasoconstrictor muscle of the abdominal aorta in Aplysia kurodai
J. Exp. Biol.,
December 1, 2004;
207(25):
4439 - 4450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakai, H. Satake, H. Minakata, and M. Takeda
Characterization of Crustacean Cardioactive Peptide as a Novel Insect Midgut Factor: Isolation, Localization, and Stimulation of {alpha}-Amylase Activity and Gut Contraction
Endocrinology,
December 1, 2004;
145(12):
5671 - 5678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kubiak, M. J. Larsen, M. R. Zantello, J. W. Bowman, S. C. Nulf, and D. E. Lowery
Functional Annotation of the Putative Orphan Caenorhabditis elegans G-protein-coupled Receptor C10C6.2 as a FLP15 Peptide Receptor
J. Biol. Chem.,
October 24, 2003;
278(43):
42115 - 42120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Dembrow, J. Jing, A. Proekt, A. Romero, F. S. Vilim, E. C. Cropper, and K. R. Weiss
A Newly Identified Buccal Interneuron Initiates and Modulates Feeding Motor Programs in Aplysia
J Neurophysiol,
October 1, 2003;
90(4):
2190 - 2204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furukawa, K. Nakamaru, K. Sasaki, Y. Fujisawa, H. Minakata, S. Ohta, F. Morishita, O. Matsushima, L. Li, V. Alexeeva, et al.
PRQFVamide, a Novel Pentapeptide Identified From the CNS and Gut of Aplysia
J Neurophysiol,
June 1, 2003;
89(6):
3114 - 3127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sasaki, Y. Fujisawa, F. Morishita, O. Matsushima, and Y. Furukawa
The enterins inhibit the contractile activity of the anterior aorta of Aplysia kurodai
J. Exp. Biol.,
November 15, 2002;
205(22):
3525 - 3533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Sweedler, L. Li, S. S. Rubakhin, V. Alexeeva, N. C. Dembrow, O. Dowling, J. Jing, K. R. Weiss, and F. S. Vilim
Identification and Characterization of the Feeding Circuit-Activating Peptides, a Novel Neuropeptide Family of Aplysia
J. Neurosci.,
September 1, 2002;
22(17):
7797 - 7808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. McDearmid, V. Brezina, and K. R. Weiss
AMRP Peptides Modulate a Novel K+ Current in Pleural Sensory Neurons of Aplysia
J Neurophysiol,
July 1, 2002;
88(1):
323 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furukawa, K. Nakamaru, H. Wakayama, Y. Fujisawa, H. Minakata, S. Ohta, F. Morishita, O. Matsushima, L. Li, E. Romanova, et al.
The Enterins: A Novel Family of Neuropeptides Isolated from the Enteric Nervous System and CNS of Aplysia
J. Neurosci.,
October 15, 2001;
21(20):
8247 - 8261.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|